Skip to main content

Table 3 Reasons why oncology experience with rituximab is most helpful

From: B cell non-Hodgkin's lymphoma: rituximab safety experience

Non-Hodgkin's lymphoma and autoimmune diseases have similarities
Provides information on chronic use
Provides a large safety database of >370,000 patient exposures
Provides 7 years of postmarketing experience
Extensive experience allows us to predict and manage infusion reactions
Low infection rate in oncology provides information on potential for infection in rheumatoid arthritis